Asimily vs Claroty
Two healthcare device security specialists that both hold KLAS recognition, split by recency against scale. Asimily is the current top rating, ranked first in the 2026 KLAS Healthcare IoT Security report at 96.6, and its distinguishing capability is contextual vulnerability prioritisation plus pre purchase device evaluation that moves risk assessment ahead of procurement. Claroty is the scale incumbent: its Medigate derived platform reports 20 million plus devices across 2,000 plus hospital facilities with a reported 500 plus protocols, and it has been named Best in KLAS across multiple years rather than one. The honest asymmetry is in the assessment itself, Claroty's record on this index is thinner, graded on fewer axes, so some comparisons rest on its described footprint rather than a graded capability. If your failure mode is the largest proven install base and broadest protocol coverage, start with Claroty. If your failure mode is contextual prioritisation and the current independent number one, start with Asimily.
- The current top independent rating: ranked first in the KLAS 2026 Healthcare IoT Security report at 96.6, the most recent buyer sourced score in the lane.
- Contextual prioritisation as the core capability: each vulnerability is evaluated against the specific device configuration and network environment rather than by CVSS score alone, addressing the unusable raw vulnerability list that defeats hospital teams.
- Capability upstream of procurement: pre purchase device evaluation assesses risk before a device is bought, plus bidirectional CMMS integration graded A on interoperability that connects security to biomedical engineering.
- The largest proven footprint in the lane: a reported 20 million plus devices across 2,000 plus hospital facilities, with device discovery across a reported 500 plus protocols through the Medigate derived platform.
- A long independent track record: named Best in KLAS for Healthcare IoT Security across multiple years, not only a single recent report.
- Purpose built healthcare device security, graded A on setting coverage, spanning IoMT, IoT, and building management systems with clinical context added to threat prioritisation.
Side-by-Side
| Axis | A Asimily |
C Claroty |
|---|---|---|
| AI Centrality | ||
| Autonomy and Oversight Model | — | |
| Model and Technology Transparency | — | |
| Clinical and Operational Evidence | ||
| AI Safety and PHI Stewardship | — | |
| HIPAA and BAA Posture | — | |
| Security Certifications and Trust Center | — | |
| FDA and Regulatory Status | — | |
| AI Governance and Bias Disclosure | — | |
| EHR and Interoperability Depth | — | |
| Deployment Model and Data Residency | ||
| Commercial Transparency | ||
| Setting and Specialty Coverage |
Both vendors grade B on AI centrality and are healthcare device security specialists with strong KLAS recognition, so this is a close pairing. A structural caveat matters for reading it: Claroty's record on this index is less fully assessed than Asimily's, carrying graded axes on AI centrality, setting coverage, clinical evidence, and deployment but not yet on model transparency, autonomy, or interoperability, so several axes where Asimily is graded show as not rated for Claroty rather than as a genuine absence of capability. Asimily's deployment counts and Claroty's device and facility counts are vendor reported. Neither publishes a security attestation such as SOC 2 Type II or ISO 27001, shared across this entire category, nor published pricing.